Table 2.
Analysis of Thyroid Carcinoma Cell Lines by Flow Cytometry for Aldefluor Activity and SSEA1 Expression
| Cell line | ALD (%) | SSEA1 (%) | Spheres % (no./total) |
|---|---|---|---|
| 16T | 4.1 ± 1.7 | 5.3 ± 1.02∗ | 68 (81/120) |
| 21T | 2.4 ± 0.2 | 3.16 ± 0.23 | 25 (3/12) |
| FRO | 3.5 ± 1.5 | 0.59 ± 0.41 | 5 (6/120) |
| KAT18 | 2.4 ± 0.2 | 0.85 ± 0.56 | 4 (2/48) |
| TPC1 | 0.1 ± 0.03 | 0.07 ± 0.04 | 25 (3/12) |
| BCPAP | 0.5 ± 0.1 | 1.99 ± 0.09 | 58 (7/12) |
ALD and SSEA1 expressed as means ± SEM. Each line was also analyzed for thyrosphere formation efficiency, (x, y) where x is the number of spheres formed, and y is the number of wells tested.
ALD, Aldefluor; SSEA1, stage-specific embryonic antigen 1.
P < 0.05.